pcess609/iStock by way of Getty Pictures
As high pharma executives arrive in San Francisco, CA, to attend the J.P. Morgan Healthcare Convention subsequent week, biotech dealmaking will probably be in focus because the annual occasion often coincides with main M&A bulletins.
With Huge Pharma dealing with important patent










